Peripheral artery disease: therapeutic advances

Area of Science:

• Vascular Medicine
• Cardiovascular Disease
• Medical Research

Background:

• Peripheral arterial disease (PAD) is a common obstructive arterial condition of the lower extremities, often caused by atherosclerosis.
• Affecting over 8.5 million people in the USA, PAD impairs arterial blood flow, leading to symptoms ranging from asymptomatic disease to critical limb ischemia.
• Patients with PAD experience limitations in exercise and walking ability, alongside an elevated risk of cardiovascular events.

Purpose of the Study:

• To review the clinical role of recent developments in the management of peripheral arterial disease.
• To explore treatment strategies aimed at decreasing cardiovascular risk and improving functional performance in PAD patients.
• To examine the current landscape of PAD treatment, including exercise, revascularization, and medical therapies.

Main Methods:

• Review of current literature on peripheral arterial disease management.
• Analysis of established and emerging treatment modalities for PAD.
• Exploration of pharmacological and interventional approaches to PAD.

Main Results:

• Supervised exercise is a primary treatment for PAD.
• Few pharmacological breakthroughs have significantly increased blood flow to ischemic limbs.
• Percutaneous intervention and bypass surgery remain important revascularization options.
• Medical therapy primarily focuses on secondary cardiovascular risk prevention (antiplatelets, statins, ACE-inhibitors, smoking cessation).

Conclusions:

• Treatment goals for PAD include reducing cardiovascular risk and enhancing exercise capacity.
• Revascularization is crucial for patients with severe symptoms like rest pain or nonhealing ulcers.
• Further research into pharmacological treatments that improve limb perfusion is warranted.